Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis

References

• Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983; 116: 880–888
   PubMed Web of Science ®Google Scholar
• Kelly J W, Colon W, Lai Z, Lashuel H A, McCulloch J, McCutchen S L, Miroy G J, Peterson S A. Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv Protein Chem 1997; 50: 161–181
   PubMedGoogle Scholar
• Connors L H, Lim A, Prokaeva T, Roskens V A, Costello C E. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003; 10: 160–184
   PubMed Web of Science ®Google Scholar
• Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002; 58: 1001–1007
   PubMed Web of Science ®Google Scholar
• Ikeda S, Takei Y, Tokuda T, Nakazato M, Ando Y. Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan. Amyloid 2003; 10(Suppl)139–147
   Google Scholar
• Dwulet F E, Benson M D. Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest 1986; 78: 880–886
   PubMed Web of Science ®Google Scholar
• Ueno S, Fujimura H, Yorifuji S, Nakamura Y, Takahashi M, Tarui S, Yanagihara T. Familial amyloid polyneuropathy associated with the transthyretin Cys114 gene in a Japanese kindred. Brain 1992; 115: 1275–1289
   PubMed Web of Science ®Google Scholar
• Garzuly F, Wisniewski T, Brittig F, Budka H. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology 1996; 47: 1562–1567
   PubMed Web of Science ®Google Scholar
• Herrick M K, DeBruyne K, Horoupian D S, Skare J, Vanefsky M A, Ong T. Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 1996; 47: 988–992
   PubMed Web of Science ®Google Scholar
• Petersen R B, Goren H, Cohen M, Richardson S L, Tresser N, Lynn A, Gali M, Estes M, Gambetti P. Transthyretin amyloidosis: A new mutation associated with dementia. Ann Neurol 1997; 41: 307–313
   PubMed Web of Science ®Google Scholar
• Brett M, Persey M R, Reilly M M, Revesz T, Booth D R, Booth S E, Hawkins P N, Pepys M B, Morgan-Hughes J A. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain 1999; 122: 183–190
   PubMed Web of Science ®Google Scholar
• Mascalchi M, Salvi F, Pirini M G, D'Errico A, Ferlini A, Lolli F, Plasmati R, Tessa C, Villari N, Tassinari C A. Transthyretin amyloidosis and superficial siderosis of the CNS. Neurology 1999; 53: 1498–1503
   PubMed Web of Science ®Google Scholar
• Uemichi T, Uitti R J, Koeppen A H, Donat J R, Benson M D. Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. Arch Neurol 1999; 56: 1152–1155
   PubMedGoogle Scholar
• Ellie E, Camou F, Vital A, Rummens C, Grateau G, Delpech M, Valleix S. Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology 2001; 57: 135–137
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Hammarström P, Matsumura M, Shimizu Y, Iwata M, Tokuda T, Ikeda S, Kelly J W. Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Lab Invest 2003; 83: 409–417
   PubMed Web of Science ®Google Scholar
• Blevins G, Macaulay R, Harder S, Fladeland D, Yamashita T, Yazaki M, Hamidi Asl K, Benson M D, Donat J R. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 2003; 60: 1625–1630
   PubMed Web of Science ®Google Scholar
• Jin K, Sato S, Takahashi T, Nakazaki H, Date Y, Nakazato M, Tominaga T, Itoyama Y, Ikeda S. Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid hemorrhages with superficial siderosis. J Neurol Neurosurg Psychiatry 2004; 75: 1463–1466
   PubMed Web of Science ®Google Scholar
• Hammarström P, Sekijima Y, White J T, Wiseman R L, Lim A, Costello C E, Altland K, Garzuly F, Budka H, Kelly J W. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: A prescription for central nervous system amyloidosis?. Biochemistry 2003; 42: 6656–6663
   PubMed Web of Science ®Google Scholar
• Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li Y F, Masuda Y, Ikeda S. Usefulness of MALDI/TOF mass spectrometry immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid 1999; 6: 282–288
   PubMed Web of Science ®Google Scholar
• Yazaki M, Yamashita T, Kincaid J C, Scott J R, Auger R G, Dyck P J, Benson M D. Rapidly progressive amyloid polyneuropathy associated with a novel variant transthyretin serine 25. Muscle Nerve 2002; 25: 244–250
   PubMedGoogle Scholar
• Murakami T, Atsumi T, Maeda S, Tanase S, Ishikawa K, Mita S, Kumamoto T, Araki S, Ando M. A novel transthyretin mutation at position 30 (Leu for Val) associated with familial amyloidotic polyneuropathy. Biochem Biophys Res Commun 1992; 187: 397–403
   PubMed Web of Science ®Google Scholar
• Reilly M M, Adams D, Booth D R, Davis M B, Said G, Laubriat-Bianchin M, Pepys M B, Thomas P K, Harding A E. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995; 118: 849–856
   PubMed Web of Science ®Google Scholar
• Yazaki M, Takei Y, Katoh M, Ikeda S. Postmortem findings in two familial amyloidosis patients with transthyretin variant Asp38Ala. Amyloid 2000; 7: 270–277
   PubMed Web of Science ®Google Scholar
• Nishi H, Kimura A, Harada H, Hayashi Y, Nakamura M, Sasazuki T. Novel variant transthyretin gene (Ser50 to Ile) in familial cardiac amyloidosis. Biochem Biophys Res Commun 1992; 187: 460–466
   PubMedGoogle Scholar
• Ueno S, Uemichi T, Takahashi N, Soga F, Yorifuji S, Tarui S. Two novel variants of transthyretin identified in Japanese cases with familial amyloidotic polyneuropathy: Transthyretin (Glu42 to Gly) and transthyretin (Ser50 to Arg). Biochem Biophys Res Commun 1990; 169: 1117–1121
   PubMed Web of Science ®Google Scholar
• Wallace M R, Dwulet F E, Conneally P M, Benson M D. Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest 1986; 78: 6–12
   PubMed Web of Science ®Google Scholar
• Takei Y, Hattori T, Yazaki M, Tokuda T, Urasawa N, Kanai S, Ikeda S. Transthyretin Tyr69-to-Ile mutation (double-nucleotide substitution in codon 69) in a Japanese familial amyloidosis patient with cardiomyopathy and carpal tunnel syndrome. Amyloid 2003; 10: 25–28
   PubMed Web of Science ®Google Scholar
• Murakami T, Tachibana S, Endo Y, Kawai R, Hara M, Tanase S, Ando M. Familial carpal tunnel syndrome due to amyloidogenic transthyretin His 114 variant. Neurology 1994; 44: 315–318
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Tokuda T, Kametani F, Tanaka K, Maruyama K, Ikeda S. Serum transthyretin monomer in patients with familial amyloid polyneuropathy. Amyloid 2001; 8: 257–262
   PubMed Web of Science ®Google Scholar
• Tojo K, Tokuda T, Yazaki M, Oide T, Nakamura A, Mitsuhashi S, Kaneko K, Maruyama K, Kametani F, Higuchi K, Ikeda S. Paraneoplastic sensorimotor neuropathy and encephalopathy associated with anti-alpha-enolase antibody in a case of gastric adenocarcinoma. Eur Neurol 2004; 51: 231–233
   PubMed Web of Science ®Google Scholar
• Nakazato M, Kurihara T, Kangawa K, Matsuo H. Diagnostic radioimmunoassay for familial amyloidotic polyneuropathy. Lancet 1984; 2: 1274–1275
   Google Scholar
• Haagsma E B, Post J G, De Jager A EJ, Nikkels P GJ, Hamel B CJ, Hazenberg B PC. A Duch kindred with familial amyloidotic polyneuropathy associated with the transthyretin Cys114 mutant. Amyloid 1997; 4: 112–117
   Web of Science ®Google Scholar
• Ando Y, Almeida M R, Ohlsson P -I, Ando E, Negi A, Suhr O, Terazaki H, Obayashi K, Ando M, Saraiva M JM. Unusual self-association properties of transthyretin Y114C related to familial amyloidotic polyneuropathy: Effects on detection and quantification. Biochem Biophys Res Commun 1999; 261: 264–269
   PubMed Web of Science ®Google Scholar
• Quintas A, Saraiva M JM, Brito R MM. The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution. FEBS Lett 1997; 418: 297–300
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Wiseman R L, Matteson J, Hammarström P, Miller S R, Sawkar A R, Balch W E, Kelly J W. The biological and chemical basis for tissue-selective amyloid disease. Cell 2005; 121: 73–85
   PubMed Web of Science ®Google Scholar
• Blake C CF, Geisow M J, Oatley S J, Rerat B, Rerat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol 1978; 121: 339–356
   PubMed Web of Science ®Google Scholar
• Soprano D R, Herbert J, Soprano K J, Schon E A, Goodman D S. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem 1985; 260: 11793–11798
   PubMed Web of Science ®Google Scholar